- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
Patent holdings for IPC class A61K 31/7125
Total number of patents in this class: 1817
10-year publication summary
|
87
|
96
|
141
|
145
|
162
|
180
|
157
|
240
|
193
|
73
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 860 |
129 |
| Alnylam Pharmaceuticals, Inc. | 1150 |
44 |
| Sarepta Therapeutics, Inc. | 378 |
33 |
| Wave Life Sciences Ltd. | 165 |
29 |
| The Board of Regents of the University of Texas System | 2202 |
28 |
| ProQR Therapeutics II B.V. | 109 |
26 |
| Hoffmann-La Roche Inc. | 3387 |
25 |
| Geron Corporation | 171 |
25 |
| Nippon Shinyaku Co., Ltd. | 329 |
25 |
| The Regents of the University of California | 19839 |
18 |
| University of Massachusetts | 2222 |
18 |
| Empirico Inc. | 79 |
18 |
| F. Hoffmann-La Roche AG | 7923 |
17 |
| Antisense Therapeutics Ltd. | 29 |
17 |
| Arrowhead Pharmaceuticals, Inc. | 293 |
17 |
| Regulus Therapeutics Inc. | 67 |
17 |
| Korro Bio, Inc. | 64 |
17 |
| Avidity Biosciences, Inc. | 147 |
17 |
| Daiichi Sankyo Company, Limited | 1855 |
16 |
| Bio-Path Holdings, Inc. | 25 |
15 |
| Other owners | 1266 |